Cartography Bio (Series A)

Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$129,999,987

Company Info
Founders
Kevin Parker
Company Description
An early-stage biotech developing best-in-class targeted medicines using CAR-T cell therapy in cancer treatment. Cartography is shaping a world in which cancer immunotherapies are designed around and directed toward the safest, most effective targets.
Market
Healthcare & Wellness
Coinvestors
8VC

Links
Back to Home Back to Healthcare and Biotech Deals View Funding Announcement